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 The generally accepted structure of a scientific paper is four sections, an 
introduction, a methods section, the results, and a discussion. This so-called 
IMRaD format is, with a few small variations, found in most research articles 
in biomedical journals. However, as a guide for someone writing up research 
data for the first time, it is far from complete – for example, there is no T for 
title or even S for summary. Nor does IMRaD explain what belongs in which 
section and how much should be included in or excluded from any section. As 
a supplement to, but not a replacement for, IMRaD research-workers could 
bear in mind the “six honest serving-men” of the poet Rudyard Kipling. These 
writer’s servants are called: What, Why, When, How, Where, and Who, and 
they can be applied to all parts of the paper – from its title down to the tables. 
 




What is IMRaD? 
 The journal Nature Medicine prints the methods section last and in smaller 
type whereas Science buries explanatory footnotes within its reference lists. 
There is nothing rigid about the way research articles are printed. The 
sequence of having an introduction followed by the methodology, then the re-
sults and lastly the discussion, the so-called IMRaD format, may have stood 
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the test of time but has it become a straitjacket? A Lancet editor, pleading for 
pluralism, referred to “temples of knowledge erected on the shaky pillars of 
IMRaD” (Fox,1991). IMRaD is certainly incomplete. For example, it says 
nothing about the title or even the summary. It is tidy, perhaps too tidy 
(Medawar, 1981). Research is a human activity in which things do not always 
go as intended yet, via IMRaD, the paper version describes perfectly planned 
and beautifully executed projects free from all accidents and human error. Nor 
does IMRaD tell the writer how much to put in or leave out or what level of 
reader to aim at. 
 To complement IMRaD, I suggest that writers remember a few lines from 
the British writer Rudyard Kipling (1865–1936). Kipling is still known for The 
Jungle Book, verses such as “If” and one or two other pieces but he is no lon-
ger fashionable as a writer of either poetry or prose. Nonetheless, he could be a 
sharp observer and he penned phrases that are now part of the English langu-
age (Cohen,1960). For example, those seeking to influence events in Afghani-
stan in the last months of 2001 would have done well to read Kipling’s lines: 
 
“At the end of the fight is a tombstone white 
with the name of the late deceased 
And the epitaph drear: ‘A fool lies here 
who tried to hustle the east’.” 
 
 Gems of wisdom also lie in the Just-So Stories, and Kipling’s “The Ele-
phant’s Child” can help the novice writer build on the IMRaD structure: 
 
“I keep six honest serving-men 
(They taught me all I knew) 
Their names are What and Why and When 
And How and Where and Who” 
 
 Courses in journalism teach items of this sort as the basic elements of good 
reporting. WWWHWaW can be just as useful in the world of scientific 
writing, and I will apply this tool to all parts of a scientific paper, from title 
onwards, and show how it can help writers to avoid some of the common mis-
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WWWHWaW Applied to IMRaD  
Introduction 
 Before you first put pen to paper or lay fingers upon a keyboard ask Why 
you are writing (Table 1). The honest answer – and, remember, Kipling’s aides 
were “honest” – may be that a paper is required for reasons to do with career 
advancement. The more usual responses are that you have interesting results to 
share with others and/or that research is nothing until it is published. But why 
write now – in other words, When does a study merit reporting (Table 1)? 
 A common fault on timing relates to the study design. If you have done a 
power calculation, a statistician will have asked you what difference between 
test and control groups will be important clinically or biologically and then es-
timated the numbers of patients or mice you will need. With some randomised 
controlled trials it may be necessary to report early, before the trial is over – 
perhaps because a planned interim analysis has suggested that it would be 
dangerous and/or unethical to continue. Usually, however, a preliminary report 
should be restricted to an interesting incidental observation in a study set up 
for some other purpose. Phased reporting of the same study is, at best, confu-
sing, especially to those who have to draw conclusions from several different 
projects (Leizorovicz et al., 1992). Sometimes this practice is referred to as 
salami publication, after the name of an Italian sausage thinly sliced. You will 
also hear the phrase “redundant publication”, a term applied to the even worse 
practice of true duplicate publication (Huth, 2000). 
 A more important Why relates to your introduction. Why did you do the 
study? At this point you will need to bring in a Who as well (Table 1). For 
whom are you writing – is it your peers, fellow experts in a narrow specialty 
who will instantly recognise the problem you have looked at and understand 
the technical language you use, or is it a less expert reader, who will need assi-
stance? (A seventh Kipling helper here might be Which, which journal are you 
submitting to; and that decision also affects the level at which your paper is 
written or rewritten.) 
 So, your introduction should set the scene, and that scene should be the 
situation when you began the research. For example, it seems illogical to cite 
in the introduction references not available when the study was conceived. A 
good, up-to-date review article, which can economically introduce the subject, 
would be an exception to that rule. Amazingly, introductions will sometimes 
include the conclusion of the article. Avoid that mistake. End this section of 
your paper with a clear statement of the hypothesis your study set out to test. 
By all means read about the hypothetico-deductive system (Medawar, 1982), 
but in print, keep it simple, and in doing so avoid post hoc adjustment; do not 
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rewrite your idea in the light of what you found. Two paragraphs or at most 
three for your introduction should be enough. 
 
Methods 
 The methodology is Kipling’s How. In the physical sciences there is a 
tradition of methods being given in great detail so that others can repeat an 
experiment exactly. For example, you will read details of the glassware used 
and the level of purity of chemical reagents and the company you bought them 
from. This can also be important in medicine, obvious examples being the 
sequences of DNA probes and the precise conditions of polymerase chain am-
plifications. However, in clinical studies exact replication is almost impossible 
since patients are neither glassware nor guinea pigs so, depending on the jour-
nal, it may be a good idea to submit for inspection by editors and referees, 
more methodology than you really expect to see published. 
 However, methods sections in medical journals are growing longer, 
especially in general journals where several specialist interests may be compe-
ting for space for their methodological detail. A separate section for statistical 
methods is common nowadays, and I cannot emphasise enough the importance 
of getting statistical advice before the research begins rather than when the 
data have been collected. Also contributing to increasing length are the many 
reporting guidelines (and pressure groups arguing for their use) for things like 
nutritional science, clinical trials and meta-analyses, and molecular genetics. If 
you have a histopathological colleague, he or she will be fussy about staining 
conditions and magnifications; radiologists have their demands too. How 
much methodology to include and when to resist the suggestions of specialist 
colleagues will depend on what the journal’s readers expect, and that can be a 
matter for negotiation with the editor at the revision stage. An invitation to re-
vise, as opposed to a straightforward, unconditional acceptance, is usually the 
best you can hope for. 
 In studies involving patients it is usual to include under methods ethical 
committee approval for the study and information about informed consent. 
 
Results 
 This is another section of your paper where sacrifices will have to be made. 
You are always going to have more data than you can publish. Few journal 
editors or their readers want to see raw data. Also, you will have many measu-
rements, especially in clinical studies, that are routine tests (e.g., automated 
analyses on blood samples) and add nothing to your study. However, raw data 
should be accessible and should be stored. An editor or journal referee may 
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ask for data, and after publication other researchers may ask for this informa-
tion. 
 The usual way of summarising large data sets is by tabulation of statisti-
cally summed information or by the use of figures. Figures may be illustrative. 
If there is room just for one or two examples these, strictly, ought to be chosen 
at random but it is only human for researchers to pick their best western blots 
or their clearest radiographs. Or figures can contain more solid data. However, 
figures are not well suited for data retrieval especially when log scales have 
been used, and scatter plots (data on individual mice or patients) can be too 
busy. How to present data represents a compromise between clarity and econ-
omy. You will not please everyone, not even yourselves probably, with this 
compromise but do avoid repetition in text, figures and tables. 
 
Discussion 
 There is no rule that says that the discussion should occupy a fixed percen-
tage of the total article length, but this section, just like the one on methods, is 
getting longer. The proportion might be small in a purely methodological pa-
per while an article recording something controversial in public-health terms 
would need to have an unusually long and careful discussion of the findings. 
All the same, as with any writing, discipline is required, and Kipling can help. 
 The key questions here are a What and a How and a Where though you may 
not be able to answer them in only three paragraphs. What were the strengths 
and weaknesses of your own study? It will have weaknesses. Something may 
have gone wrong (e.g., you were unable to recruit enough patients or crucial 
samples went missing) or perhaps a better method has been described since 
you set up your project. Then How do your findings fit in with work published 
by others? You will not be able to cite everything that has been printed on the 
subject, and many of the hours you diligently spent in the library or on the In-
ternet must go unacknowledged. Finally, Where is this line of research going 
next? This is when you face the challenge of deciding whether your original 
hypothesis is still standing. Discussion sections can drag on and the above 
three restraints may prevent that happening. 
 Just as bold statements such as “This drug will safely cure all patients with 
that disease” are best avoided in medical writing, you should avoid being 
overcautious too. This means not using too many qualifying words such as 
“possibly”, “maybe”, “perhaps”. Some people, even some editors, think that 
these words are the mark of true scholarship; good academics, in other words, 
should never make statements that lack an escape route. Think of caution an-
other way, a non-Kiplingesque, mathematical way. Suppose that any qualify-
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ing word dilutes the certainty of a statement by one-third. The phrase “We 
tentatively suggest that X may possibly cause Y” contains four diluents and 
their effects are multiplied. The certainty of “X causes Y” is diluted with every 
step to 2/3rds certain. You finish up with a very uncertain 16/81sts, which is 
only 20% sure and not what you meant. 
 
What IMRaD Does Not Do 
 IMRaD does not say anything about a paper’s title, authorship, or sum-
mary. The conclusion, acknowledgments section, and references are neglected 
too. As an acronym TASIMRaDCAR will never achieve IMRaD’s fame but 
we can still bring Kipling’s helpers to bear on the new components (Table 2). 
 
Title 
 Journals will often have their own preferences. They may, for example, not 
like declamatory titles, extreme examples of which would be “The cause of A 
is B” or “C is the drug of choice for…”; they may hate two-part titles; or they 
may not care how long a title is. At least titles are negotiable, so you, as aut-
hor, need to think What the title is meant to do and Who are you writing for. 
Read the journal and familiarise yourself with its approach to titles. Remember 
with two-part titles that the second part may be omitted in citations and by se-
arching services so it is sensible to ensure that keywords are in your title. 
Some journals will ask you to provide keywords on the title page of your article. 
 
Authorship 
 This has become a serious Who question, especially in medical journals. A 
definition by the International Committee of Medical Journal Editors (ICMJE) 
(2001), though useful, is now generally accepted to be too strict, and some jo-
urnals are showing more interest in publishing the contributions that authors 
made to the study and resulting paper (Rennie, et. al. 1997; Horton, 2000). In 
May 2000, the ICMJE relaxed its position a little. Deciding on authorship be-
fore the study begins is a good idea though in a study that takes years to com-
plete, the research team may change significantly. All “authors” should have 
seen and approved the final version as submitted for publication, and whatever 
the journal’s policy is, it is a good idea to agree as the study progresses on 
what roles deserve authorship as opposed to acknowledgment. 
 In some branches of physics no one seems to care about how many authors 
there are and hundreds are not uncommon. From a botanist came an ingen-
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iously democratic method intended for deciding on authorship before writing 
begins (Hunt, 1991) but this may also help to resolve disputes. 
 
Summary (or Abstract) 
 Summaries and abstracts were different in times gone by but today the 
differences are blurred. Summaries used to be very short and they appeared at 
the end of the article. They lacked structure, said very little, and employed the 
passive voice (“were studied” and “is discussed”) with little hard information. 
All that has changed. Today they tend to be structured more or less on IMRaD 
lines and they appear at the beginning. Often the abstract will be all that a lite-
rature search engine (e.g., the US National Library of Medicine’s PubMed) 
will provide free of charge, and it is a sad fact that many readers will not per-
sist beyond your summary. Summaries are therefore important. Always check 
that everything in the summary is provided in and is compatible with your text. 
The reverse – everything that is in the paper should be in the summary – is 
clearly absurd. However, in the necessary compression you must not oversim-
plify the message of your paper. 
 
Conclusion 
 If your journal of choice prints conclusions, you should provide one. How-
ever, with modern summaries and disciplined discussion sections, a conclusion 
should not be necessary and many medical journals do not have them. 
 
“Acknowledgements” 
 This section, almost always printed in smaller type than the paper itself, 
used to be very simple. Authors would thank their secretaries and one or two 
other people and mention who provided funds for the research, and that was 
that. Today, this tailpiece to a paper is expanding and acquiring a structure of 
its own, which is why I have used quotation marks around the word. For 
example, you need to ask, in thanking someone for what they did, if that con-
tribution actually merits full authorship (see above). If authors’ contributions 
are published, they will appear in or near this section, as will any authors’ con-
flicts of interest, financial or other. Clinical research often depends on the ge-
nerous but unrewarded input of doctors, nurses and other healthcare workers, 
and in former times this was often taken for granted. Today, thanking them by 
name in print is more than a courtesy; it is a good investment for future colla-
boration. 
 




 There are three basic ways of setting out references. The Harvard system 
with authors’ names and the date of publication in the text and the reference 
list alphabetical by first author; the numbered list in which references numbers 
are given in the text and the list at the end of the paper follows the numerical 
order; and the hybrid alphanumeric system with a numbered alphabetical list 
resulting in non-sequential numbering in the text. Most journals (Nature and 
Science are exceptions) give the titles of papers cited. 
 Why do authors provide references and What are they for? If the purpose is 
simply to tell the reader which shelf in a library to go to, a very simple code 
(e.g., the international serials number for the journal, the volume and the first 
page) would usually suffice. In today’s world of electronic access this is 
increasingly being achieved by the digital object identifier (DOI) for the arti-
cle. In print such codes do not tell the reader who wrote the paper or how long 
it was and what its title was. These days, thanks to the activities of the ICMJE, 
there is a consensus that medical journals will be happy to look at papers in the 
ICMJE style (2001), which is numerical referencing in the text and a listing 
with authors, title, abbreviated journal title, year, volume, and first and last 
page numbers. Journals may print references differently but that is their problem. 
 Errors in references are common (Faunce, 2001). Even if they seem trivial 
they will look, to editors and referees, like carelessness. Never cite something 
you have not read. I once saw in the list for a paper on hepatitis B antigen 
(which was then called Australia or Au antigen) a paper from a metallurgy jo-
urnal about gold, whose chemical symbol is Au. References need to be acces-
sible and some journals do not allow references to conferences proceedings 
and abstracts and will have strict rules about “personal communications”. 
Websites are allowed but their impermanence worries editors (Cheung, 2001). 
 
Instructions to Authors 
 The ICMJE’s “Uniform Requirements” (2001) is a useful guide but most 
journals have their idiosyncrasies so do read the information for authors, pro-
vided in the printed journal you have chosen and/or on its website1. This ad-
vice will often go beyond pedestrian instructions such as “double-spaced typ-
ing on one side of the paper”. For example, The Lancet’s guidance2 explains 
                                                 
1 Or on a compendium site: Raymond H. Mulford Library, Medical College of Ohio. 
Instructions to authors in the health science.  
2 Information for authors (Lancet, 2002: 359) 
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what the journal’s many sections are for and tells authors how their paper will 
be handled. 
 
The Electronic World 
 By giving pointers to writing, using the device of Kipling’s helpers to sup-
plement the classical IMRaD model, I have tacitly assumed the printed word. 
Of course, you will be using a PC not a typewriter; you will be asked to supply 
a disc as well as printed copies; you may even submit the whole paper via the 
journal’s website with no paper; journals increasingly use electronic means to 
referee papers and they almost always use electronic production methods. We 
are, after all, in the 21st century (Wood, 2002). However, the object of publi-
cation – to share with others the fruits of your labour and to do so in as clear 
and economical way as possible – remains the same whether we live in a pa-
per-only world, an e-only world (the future, some say), or both together. 
 
Do Not Be Afraid 
 Time and again, when I have given talks on editing and writing, in countri-
es where English is not the first language, I have been asked questions that 
imply that the audience is afraid to submit to British and American journals or, 
worse, that the audience believes that the editors of those journals are biased 
against papers from such countries. Editors want to publish good work; rese-
arch quality is the criterion, and journals will want to help you if the 
underlying quality is good. Perhaps scientific writing should always be taught 
alongside seminars on research methodology. Good prose cannot correct bad 
work. Anyway, poor communication is not restricted to those who day to day 
speak a language other than English. English has become the common langu-
age of medical science, and many journals published outside the Anglophone 
world (e.g., the Croatian Medical Journal) now use English. However, authors 
should not be worried about “American vs British English”. The differences 
are rarely important for scientific writing. 
 Here in further tables are a few hints for the non-English-speaker (Table 3) 
and some personal suggestions about the books that medical writers may like 
to have, in departmental or central libraries or, funds permitting, on their own 
desks (Table 4). These tables, indeed the whole of this article, are published in 
the hope that readers in Croatia (a country where spoken English is well taught 
and often excellent) will be encouraged to submit their research to English-
language journals in the UK and USA. 
 




 Based on a talk given at University of Rijeka, Croatia, on June 14, 2001. 
 I thank Prof Ana Marušiæ and Prof Matko Marušiæ for the invitation to the 
June 2001, workshop in Rijeka, Croatia, with which this article began, and the 
local organisers for funding the travel for that visit. 
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Table 1. Applying Kipling’s helpers to traditional IMRaD 
IMRaD section WWWHWaW questions 
Why are you writing – and why now? 
Who are you writing for? 
Who is doing the writing? Introduction 
What problem are you addressing; what is the background to it; 
and what is the prior hypothesis you were testing? 
How did you do the study? 
Methods What materials did you use or what types of patient did you 
study? 
What did you find? 
How much can you include? Results 
What belongs in tables or figures and what is better in the text? 
What are the strengths and weaknesses of your study? 
How do your findings fit (or not) with other published evidence? 
Discussion Where now -ie, what comes next in your research and has your 
prior hypothesis stood up to your test of it or should you modify it 
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Table 2. Applying Kipling to TASCAR, the non-IMRaD parts of your paper 
Section Notes 
Title How long; how many parts; declamatory (or not)? 
Authorship Who is best defined in advance; what does “authorship” mean; how many? 
Summary What structure; where to place it; how long? 
Conclusion Who needs one? 
Acknowledgments Who should be thanked; who paid; who has conflicts? 
References How many; what are they for; how to set them out? 
 






Do not rewrite for ever; the final version may well be worse than 
the third. Put the penultimate (e.g., third) draft in a drawer for a co-
uple of days and then look at it with fresh eyes. You will need to 
revise it after refereeing anyway and that is the time for very minor 
adjustments of your own. 
Do not write in 
your mother 
tongue 
You can do this, later translating into English yourself or 
employing a translator, but at some point you will discover the ad-
vantages of using English first. 
Show the 
paper to others 
Colleagues in your own specialty if you wish but also someone in 




This can be done by sending the draft to a UK or US colleague or 
by making use of local language expertise. Some universities in Eu-
rope provide an “author's editor” service or you may have to pay for it. 
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Table 4. Suggestions for a medical writer’s library 
Short title Notes 
ICMJE style (7) These style guidelines are broadly accepted 
CBE [now CSE] style (16) More detailed on specific points of style 
AMA style (17) Similar to CBE 
Cambridge style (18) For editors but authors also 
Journal instructions (13) A compendium of 3500 journal guidelines 
PubMed (19) Reference searching, checking; journal abbreviations 
Hart (20) Aid for printers, copy editors – and authors 
Strunk and White (21) Similar to Hart 
Fowler (22) Guide to grammar and controversies in English 
English dictionary (23, 24) Plenty of other choices, of course 
Medical dictionary (25,26) Again, plenty of choice 
Journals now and then (27, 28) History of medical journals 
Roget (29) Thesaurus; alternative words 
Ethical issues (30) Medical journal controversies 
Dates (31) Medical history 
Quotations (32,33) General and specialist medical 
Writing (34-36) There are several other good, short books 
Peer review (37,38) Understand what referees do to your paper and why 
Most of these are on the author’s personal bookshelf; the edition cited may not be the 
most recent. 
 









 Općenito prihvaćena struktura znanstvenoga rada sastoji se od četiri dijela: 
uvoda, metode, rezultata i rasprave. Taj takozvani IMRaD format s malim va-
rijacijama koristi se većinom za članke koji donose rezultate istraživanja, u ča-
sopisima iz biomedicine. Međutim, kao vodič za nekoga tko po prvi puta pri-
stupa pisanju znanstvenog rada, nije cjelovit jer na primjer u njemu nema slova 
T (title) – za naslov, kao ni slova S (summary) – za sažetak. IMRaD također ne 
objašnjava što pripada nekom poglavlju ni što treba uključiti ili isključiti iz 
određenog poglavlja. Kao dodatak, ali ne i zamjena, IMRaD istraživač mora 
imati na umu Kiplingovih “six honest serving-men”. Ti autorovi pomoćnici 
zovu se Što, Zašto, Kada, Kako, Gdje i Tko, te mogu biti primijenjeni u sva-
kom dijelu rada počevši od naslova pa do tablica.     
  
Ključne riječi: pisanje znanstvenog rada, autorstvo, IMRaD format, biomedi-
cinski časopisi 
 
